| Literature DB >> 35223414 |
Dinesh C Sirisena1,2, Shauna H-S Sim1, Ivan Lim2, Vaikunthan Rajaratnam1.
Abstract
Cycling is popular internationally as a mode of transport and sport. Cyclists often report sensory and motor changes in the hands during rides. In the past, assessment of these symptoms was based on clinical history, physical examination and neurophysiology. The aim of this narrative review was to evaluate existing publications and determine if there are areas for further improvement in the clinical setting.Entities:
Keywords: Compressive neuropathy; Cycling; Median nerve; Screening; Ulnar nerve; Ultrasound
Year: 2021 PMID: 35223414 PMCID: PMC8823486 DOI: 10.37796/2211-8039.1143
Source DB: PubMed Journal: Biomedicine (Taipei) ISSN: 2211-8020
MeSH and additional terms used for the literature search.
| MeSH terms | Additional synonyms |
|---|---|
| Bicyclist | Cyclist |
| Median nerve | Cycling |
| Ulnar nerve | Bicycling |
| Median neuropathy | |
| Ulnar neuropathy |
Fig. 1Outline of the review process following PRISMA guidelines 17.
Case study quality assessment using the NHLBI guidelines for cohort and case studies/series [19].
| Author | Was the study question or objective clearly stated? | Was the study population clearly and fully described, including a case definition? | Were the cases consecutive? | Were the subjects comparable? | Was the intervention clearly described? | Were the outcome measures clearly defined, valid, reliable, and implemented consistently across all study participants? | Was the length of follow-up adequate? | Were the statistical methods well described? | Were the results well described? | Score |
|---|---|---|---|---|---|---|---|---|---|---|
| Braithwaite [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Ali, Delamont, Jenkins, Bland, Mills [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Eckman, Perlstein, Altrocchi [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Noth, Dietz, Mauritz [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Frontera [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Haloua, Collin, Coudeyre [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Hankey, Gubbay [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Maimaris, Zadeh [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Brandsma [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Capitani, Beer [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
| Selçuk, Kurtaran, Yildirim, Değirmenci, Akyüz [ | Yes | Yes | No | Yes | No | Yes | No | No | Yes | 8 |
Cohort study quality assessment using the NHLBI guidelines for cohort studies [19]. (Q1: Was the research question or objective in this paper clearly stated? Q2: Was the study population clearly specified and defined? Q3: Was the participation rate of eligible persons at least 50%? Q4: Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for the study prespecified and applied uniformly to all participants? Q5: Was a sample size justification, power description, or variance and effect estimates provided? Q6: For the analyses in this paper, were the exposure(s) of interest measured before the outcome(s) being measured? Q7: Was the time frame sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? Q8: For exposures that can vary in amount or level, did the study examine different levels of exposure as related to the outcome (e.g., categories of exposure or exposure measured as a continuous variable)? Q9: Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? Q10: Was the exposure(s) assessed more than once over time? Q11: Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? Q12: Were the outcome assessors blinded to the exposure status of participants? Q13: Was loss to follow-up after baseline 20% or less? Q14: Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)?).
| Author | Q1. | Q2. | Q3. | Q4. | Q5. | Q6. | Q7. | Q8. | Q9. | Q10. | Q11. | Q12. | Q13. | Q14. | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patterson, Jaggars, Boyer [ | Yes | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 7 | |||
| Akuthota, Plastaras, Lindberg, Tobey, Press, Garvan [ | Yes | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 7 |
Overall findings from the study with key findings and evidence levels based on the 2011 Oxford CEBM Evidence Levels of Evidence [18].
| Author | Study type | Type of cyclist | Inciting event | Number/gender | Nerves considered | Primary assessment | Other assessments | Results | Interventions | Evidence level |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Braithwaite [ | Case report | Road | 100-mile ride | 1 male | Median | Clinical assessment | None | Cortisone injection is given to relieve symptoms | 4 | |
| Ali, Delamont, Jenkins, Bland, Mills [ | Case report | Road | 300-km ride | 1 male | Median | Clinical assessment | Neurophysiology and ultrasound | None | 4 | |
|
| ||||||||||
| Eckman, Perlstein, Altrocchi [ | Case report | Road | 3000-mile ride | 1 male | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
| Noth, Dietz, Mauritz [ | Case series | Road | 400 –2000-km rides | 3 male and 1 female | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
| Frontera [ | Case report | Road | 20-km ride | 1 male | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
| Haloua, Collin, Coudeyre [ | Case series | Road | 100–700-km rides | 2 male and 1 female | Ulnar | Clinical assessment | None | None | 4 | |
| Hankey, Gubbay [ | Case series | Road | Daily cycling, up to 2–4 h per day | 1 male and 1 female | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
| Maimaris, Zadeh [ | Case series | Mountain and road | 120–195-km rides | 2 male | Ulnar | Clinical assessment | None | None | 4 | |
| Brandsma [ | Case report | Road | Not stated | 1 male | Ulnar | Clinical assessment | None | Hand therapy and evaluation muscle with strength testing | 4 | |
| Capitani, Beer [ | Case series | 1 road and 2 mountain | 5000-km ride and downhill riding | 3 male | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
| Selçuk, Kurtaran, Yildirim, Değirmenci, Akyüz [ | Case report | Leisure | 3–4-h bi-cycle lesson | 1 female | Ulnar | Clinical assessment | Nerve conduction studies | None | 4 | |
|
| ||||||||||
| Patterson, Jaggars, Boyer [ | Cohort | 16 road and 9 mountain | 600-km ride | 13 male and 12 female | Ulnar and median | Clinical assessment for motor and sensory changes | None | N/A | 3 | |
| Akuthota, Plastaras, Lindberg, Tobey, Press, Garvan [ | Cohort | Road | 420-mile tour | 7 female 7 male | Ulnar and median | Nerve conduction studies | None | Distal motor latencies of the deep branch of the ulnar nerve to the FDI were prolonged after the event (p < 0.05). Three subjects had CTS before that worsened after the event, and one developed CTS changes in the median nerve after the event. | N/A | 3 |